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We show here that the African swine fever virus (ASFV) protein pE296R, predicted to be a class II
apurinic/apyrimidinic (AP) endonuclease, possesses endonucleolytic activity specific for AP sites. Biochemical
characterization of the purified recombinant enzyme indicated that the Km and catalytic efficiency values for
the endonucleolytic reaction are in the range of those reported for Escherichia coli endonuclease IV (endo IV)
and human Ape1. In addition to endonuclease activity, the ASFV enzyme has a proofreading 335 exonuclease
activity that is considerably more efficient in the elimination of a mismatch than in that of a correctly paired
base. The three-dimensional structure predicted for the pE296R protein underscores the structural similarities
between endo IV and the viral protein, supporting a common mechanism for the cleavage reaction. During
infection, the protein is expressed at early times and accumulates at later times. The early enzyme is localized
in the nucleus and the cytoplasm, while the late protein is found only in the cytoplasm. ASFV carries two other
proteins, DNA polymerase X and ligase, that, together with the viral AP endonuclease, could act as a viral base
excision repair system to protect the virus genome in the highly oxidative environment of the swine macro-
phage, the virus host cell. Using an ASFV deletion mutant lacking the E296R gene, we have determined that
the viral endonuclease is required for virus growth in macrophages but not in Vero cells. This finding supports
the existence of a viral reparative system to maintain virus viability in the infected macrophage.
Base excision repair (BER) is the major system for the
repair of DNA base lesions such as the products of deamina-
tion, oxidation, and alkylation, all of which can arise endog-
enously (22). As such, BER plays an essential role in the
protection of cells against the lethal and mutagenic effects of
DNA damage. BER is a multistep process composed of se-
quential reactions that are proposed to occur in a highly co-
ordinated manner. The mammalian DNA polymerase  (Pol
)-dependent short-patch pathway of BER starts with a mono-
functional DNA glycosylase that excises the damaged base,
generating an abasic site that is subsequently incised at the 5
side of the lesion by an apurinic/apyrimidinic (AP) endonucle-
ase, leaving a 5-terminal deoxyribose phosphate (dRP) (23,
24). This dRP group is eliminated by the dRP lyase activity of
Pol  after the gap-filling step (25, 37). Finally, a DNA ligase
seals the nick.
A key enzyme of this system is the AP endonuclease, not
only because of its endonucleolytic activity, which can resolve
mutagenic AP sites, but also because it is able to eliminate 3
blocking groups, such as phosphates, phosphoglycolates, and
,-unsaturated aldehydes arising in DNA as products of re-
active oxygen species (ROS) attack or generated by enzymatic
AP lyase activity, all of which block DNA replication (11).
Furthermore, AP endonucleases may interact with and coor-
dinate other enzymes involved in the short-patch route of
BER, such as Pol  (2, 44), or in the long-patch subpathway of
BER, such as flap endonuclease (Fen) and proliferating cell
nuclear antigen (7).
African swine fever virus (ASFV), a complex and enveloped
deoxyvirus with icosahedral morphology, is responsible for a
highly lethal disease of domestic pigs (33). The virus replicates
mainly in the cytoplasm of the infected cell, but an initial phase
of viral DNA replication in the nucleus has been described (13,
32). The viral genome is a double-stranded DNA molecule of
170 to 190 kbp that encodes more than 150 polypeptides,
including a variety of enzymes involved in gene transcription,
protein modification, and DNA replication and repair (46).
Among these is the smallest naturally occurring DNA-directed
DNA polymerase (174 amino acid residues) described so far
(27). This DNA polymerase, designated Pol X, is a highly
distributive -type polymerase lacking a proofreading 335
exonuclease activity that has been proposed to participate in a
BER pathway during ASFV infection (14, 27). In addition, the
viral protein pE296R has been annotated as a class II AP
endonuclease, while the NP419L gene codes for a DNA ligase
(46, 47), which further supports the existence of a BER-like
pathway acting in ASFV-infected cells (14, 27). A viral BER
process may be crucial for maintaining the integrity of the viral
genome in the highly oxidative and potentially mutagenic en-
vironment of the swine macrophage (26), the ASFV host cell.
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For this work, we purified and characterized the protein
codified by the ASFV E296R gene. We show that the recom-
binant protein possesses an endonuclease activity specific for
AP sites, as well as 335 exonuclease activity. The latter
activity may act as a proofreading backup system to increase
the fidelity of DNA repair. By using an ASFV deletion mutant
lacking the E296R gene, we also show that the viral AP endo-
nuclease is essential for virus growth in swine macrophages but
not in Vero cells. These results support a role for the viral AP
endonuclease in a reparative BER system to maintain the
viability of the virus in its natural target cell.
MATERIALS AND METHODS
Amino acid sequence comparisons. The multiple sequence alignment of the
endonuclease IV (endo IV) subfamily of class II AP endonuclease sequences
shown in Fig. 1 was done with Clustal_X (38). All sequences are from the NCBI
Protein Database.
Oligonucleotides and proteins. The oligonucleotides used in this work are
shown in Table 1. They were purchased from Isogen. EndoU, Endo11, and
Endo11MM were purified by 7 M urea-20% polyacrylamide gel electrophoresis
(PAGE) before use.
Restriction endonucleases, T4 polynucleotide kinase, Escherichia coli uracil
DNA glycosylase (UDG), and E. coli endo IV were purchased from New
England Biolabs.
Expression and purification of ASFV protein pE296R. The E296R open read-
ing frame (ORF) of ASFV cloned in pRSET-A was expressed in E. coli
BL21(DE3)/pLys at 30°C in the presence of 0.4 mM IPTG (isopropyl--D-
thiogalactopyranoside) for 3 h. Cells were collected by centrifugation for 15 min
at 2,000  g and resuspended in 10 ml of buffer A (50 mM phosphate buffer, pH
8, 1 M NaCl, and 20 mM imidazole). After sonication on ice, an aliquot was
withdrawn as total cell extract. The suspension was cleared by centrifugation for
20 min at 20,000  g, and the soluble supernatant fraction was used for affinity
purification.
Ni-nitrilotriacetic acid (Ni-NTA) agarose beads (QIAGEN), previously equil-
ibrated in buffer A, were added to the soluble fraction containing the recombi-
nant protein. After being stirred for 2 h at 4°C, the resin was washed in batches
twice with 25 resin volumes of buffer A and then loaded onto a column. Elution
was carried out in two steps, with 60 and 250 mM imidazole in buffer B (50 mM
phosphate buffer, pH 6, 1 M NaCl). Five 0.5-ml fractions were collected at each
step. The fractions were analyzed by sodium dodecyl sulfate-PAGE (SDS-
PAGE) followed by staining with Coomassie brilliant blue, and the last four
fractions eluted with 250 mM imidazole were pooled, dialyzed against 80 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 4 mM dithiothreitol, diluted one-half with
100% glycerol, and stored at 20°C.
Enzymatic assays. The oligonucleotides used were 5 labeled with T4 polynu-
cleotide kinase and [-32P]ATP (3,000 Ci/mmol; Amersham International Plc.)
and purified with a nucleotide removal kit (QIAGEN). After incubation with a
1.5-fold excess of the complementary strand for 10 min at 80°C in 30 mM
Tris-HCl [pH 8]–10 mM NaCl, the solution was slowly cooled to room temper-
ature for 1 h. One picomole of the double-stranded, end-labeled substrate was
incubated with the indicated enzyme in optimized buffer (25 mM Tris-HCl, pH
8, 10 mM NaCl, and 5 mM MgCl2) in a final volume of 50 l for AP endonu-
clease assays. For 335 exonuclease assays, the final reaction volume was 30 l,
and ZnCl2 was used instead of MgCl2. In all cases, incubations were done for 45
min at 37°C, and the reactions were stopped by adding an equal volume of
formamide loading buffer (98% formamide, 20 mM EDTA, 0.5% bromophenol
blue, and 0.5% xylene cyanol). The samples were heated for 10 min at 95°C and
immediately placed on ice before being loaded into a 20% polyacrylamide–7 M
urea–1 Tris-borate-EDTA gel. After electrophoresis, the product bands were
detected by autoradiography and measured by densitometry with Quantity One
software (Bio-Rad). Kinetic parameters were determined using reaction times,
and enzyme concentrations were adjusted to a linear steady state. Km and Vmax
values were determined from fitted Lineweaver-Burk plots.
Antibodies. Antibodies against purified His-tagged pE296R were raised in
rabbits. The immune serum obtained recognized the recombinant protein in
Western blots. The rat anti-p54 protein, as well as the rabbit anti-pE248R and
anti-pB119L proteins, has been described previously (28, 30). Anti-tubulin and
anti--actin monoclonal antibodies were purchased from Sigma.
Cells and viruses. Vero cells were obtained from the American Type Culture
Collection and grown in Dulbecco modified Eagle medium (DMEM) containing
5% fetal calf serum. Swine alveolar macrophages, obtained as described previ-
ously (4), were grown in DMEM containing 10% swine serum. Cell infections
with the ASFV BA71V strain and titrations were carried out as previously
described (8). Highly purified ASFV was prepared as described before (3).
The E296R deletion virus was obtained by insertion of the gusA gene of E. coli
into the E296R ORF of the Vero-cell-adapted ASFV strain BA71V. A 1,318-bp
DNA fragment containing the E296R gene was generated by PCR using the
primers 	E296R-1 and 	E296R-2 and Vent DNA polymerase (New England
Biolabs). The PCR product was cloned into EcoRV-digested pZErO (Invitro-
gen), generating the plasmid pZErO-E296R. Plasmid p72Gus10T (12) was di-
gested with SmaI/HindIII and treated with Klenow fragment. The fragment
obtained was cloned into AvrII-digested pZErO-E296R, which was previously
treated with Klenow fragment to obtain the transfer vector p	E296R-Gus. The
recombinant BA71V-	E296R (v	E296R) virus was generated in Vero cells and
purified by sequential rounds of plaque purification in the presence of 5-bromo-
4-chloro-3-indolyl--D-glucuronic acid (X-Gluc) as previously described (29).
The disruption of the E296R gene was confirmed by DNA hybridization and
Western blot analysis of v	E296R-infected Vero cells (data not shown).
Analysis of pE296R expression in ASFV-infected Vero cells. Vero cells in
DMEM containing 2% fetal calf serum were either mock infected or infected
with ASFV BA71V at a multiplicity of infection (MOI) of 10 PFU per cell, and
at different times postinfection, the cells were lysed in electrophoresis sample
buffer at a density of 3  106 cells per ml. Equivalent amounts of the cell lysates
were electrophoresed in 12% SDS-polyacrylamide gels and subsequently trans-
ferred to nitrocellulose membranes for Western blot analysis. The membranes
were incubated with the antibody against the pE296R protein (1:2,000 dilution)
and then with a 1:10,000 dilution of peroxidase-labeled anti-rabbit serum (Am-
ersham International Plc.). The proteins were detected with the ECL system
(Amersham International Plc.) according to the manufacturer’s recommenda-
tions.
Immunofluorescence. Vero cells grown in chamber slides were either mock
infected or infected with BA71V or v	E296R at an MOI of 10 PFU per cell and
then fixed at different times postinfection with 4% paraformaldehyde–2% su-
crose in 1 phosphate-buffered saline (PBS) for 15 min at room temperature,
followed by 5 min with methanol at 20°C. Fixed cells were washed twice with
1 PBS and blocked for 30 min with blocking buffer (3% bovine serum albumin,
0.1% Triton X-100, 1 PBS). The cells were then sequentially incubated for 1 h
with primary antibodies and the corresponding secondary antibodies diluted with
1% bovine serum albumin in 1 PBS. The primary antibodies were used at the
following dilutions: anti-tubulin, 1:200; anti-p54, 1:200; and anti-pE296R, 1:500.
The secondary antibodies used were goat anti-mouse, goat anti-rat, and goat
anti-rabbit immunoglobulin G coupled to Alexa 594, Alexa 697, and Alexa 488,
respectively (1:500 dilution) (Molecular Probes). After incubation with the an-
tibodies, the cells were washed three times for 15 min each in 1 PBS. Finally,
the coverslips were mounted with Mowiol/Dabco on glass slides. Preparations
were examined with a Bio-Rad Radiance 2000 confocal laser scanning micro-
scope. Images were processed using Adobe Photoshop software.
RESULTS
ASFV protein pE296R contains the conserved catalytic cen-
ter of E. coli endonuclease IV. By complete DNA sequencing of
the ASFV BA71V strain and subsequent database searches for
amino acid sequence similarities, it had been reported that the
ASFV E296R ORF potentially encoded a class II AP endonu-
clease (46). Figure 1 shows a multiple amino acid sequence
alignment of ASFV protein pE296R and selected members of
the E. coli endo IV subgroup of the class II AP endonuclease
family. A dendrogram obtained from this alignment (not
shown) indicates that the ASFV protein pE296R more closely
resembles endo IV from Acanthamoeba polyphaga mimivirus,
which has been reported to be related to ASFV (20). All of the
residues that are involved in catalytic Zn atom coordination
(15) are fully conserved (residues in white below open circles in
Fig. 1), except for E261 of endo IV, which is not conserved in
the ASFV protein. Amino acids that stabilize the AP site by
stacking interactions with base pairs at the 3 and 5 ends are
also highly conserved (residues in yellow below yellow circles).
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FIG. 1. Multiple amino acid sequence alignment of M. pneumoniae (END4_MYCPN), B. anthracis (1XP3_BANTH), T. maritima
(END4_THEMA), E. coli (nfo/END4_ECOL), C. elegans (CeAPN1), S. cerevisiae (APN1_SC), Acanthamoeba polyphaga mimivirus
(END4_Mimi), and ASFV (ASFV_E296R) endonuclease IV family proteins, highlighting metal-binding active residues (white letters and open
circles at the top of the alignment) and AP-site stabilization residues (yellow letters and yellow circles). Functional enzyme motifs, including the
minor groove and phosphate-binding loops, are boxed in navy blue and magenta, respectively. The relative similarity of residues at each position
as well as the amino acid background coloring is shown according to Clustal_X codes. Above the sequences, hollow boxes indicate helices and black
arrows show strands (taken from the crystal structure of endo IV) (15).
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The sugar-phosphate backbone interaction residues are clearly
conserved in the enzymes of E. coli, Bacillus anthracis, Myco-
plasma pneumoniae, Candida elegans, and Saccharomyces cerevi-
siae, whereas the Thermotoga maritima, mimivirus, and ASFV
proteins show more sequence diversity (magenta boxes). Never-
theless, this diversity does not essentially modify the DNA recog-
nition loop (R loop) predictions (see below), and therefore the
proposed mechanism (15) for interaction with productively
cleaved AP site-containing DNA could be applied to all the en-
zymes in the group.
Expression and purification of recombinant protein pE296R.
In order to characterize the ASFV pE296R protein, the E296R
ORF was cloned into the pRSET-A vector and expressed in E.
coli. As shown in Fig. 2, a protein of about 34 kDa, the size
expected for the recombinant protein, was detected in total
lysates from cells induced with IPTG. Based on the His tag
present at its N-terminal end, the recombinant protein could
be purified from the soluble fractions of these lysates in a
single step by Ni-NTA affinity chromatography (see Materials
and Methods). After purification, a major band corresponding
to the recombinant pE296R protein could be observed (Fig. 2).
Enzymatic properties of ASFV AP endonuclease. The pre-
dicted AP endonuclease activity of the recombinant pE296R
protein was examined using a 5-32P-labeled 30-mer double-
stranded oligonucleotide containing a uracil (U) residue at
position 12 (Fig. 3A). This substrate was incubated with E. coli
UDG to remove the U residue and generate an AP site and
with various amounts of the purified recombinant pE296R
protein. AP endonucleolytic activity would release a 32P-la-
beled cleavage product of 11 nucleotides. As shown in Fig. 3A,
the pE296R protein exhibited AP endonuclease activity in a
dose-dependent manner (lanes 5 to 9). As shown, no activity
was detected in the absence of UDG (lane 3), indicating the
requirement of an AP site for endonuclease activity. As also
shown in lane 3 of Fig. 3A, no contaminating nuclease ac-
tivity was detected in the purified recombinant protein prep-
aration used.
Figure 3B shows the pH, ionic strength, and divalent cation
dependence of ASFV AP endonuclease activity. As can be
seen in this figure, the AP endonuclease was active over the
range from pH 6.0 to pH 8.5, with the highest activity obtained
at pH 8.0. The AP endonuclease showed maximal activity in
the presence of 10 to 20 mM NaCl, with concentrations of 100
mM and higher being strongly inhibitory. MgCl2 stimulated the
activity, with maximal stimulation in the 4 to 10 mM range.
The class II AP endonucleases have also been described to
possess a 335 proofreading exonuclease activity specific for
double-stranded DNA that may improve the fidelity of BER by
removing mispaired bases (6, 18, 39, 40, 42). To see whether
the viral enzyme possesses this activity, we used a 30-mer
duplex substrate with a 19-base recessed 3 end or an internal
nick, with or without a mismatch at the 3 end of the recessed
oligonucleotide or at the 3 side of the nick (Fig. 4). As shown
in Fig. 4, the viral AP endonuclease exhibited dose-dependent
335 exonuclease activity with all substrates tested. Interest-
ingly, this activity was essentially limited to the removal of the
last nucleotide at the 3 end of the 5-32P-labeled oligonucle-
otide and more efficiently eliminated a mismatched than a
correctly paired base. It is also noteworthy that the best sub-
strate for the enzyme was the nicked oligonucleotide with a
mismatch, which resembles DNA intermediates arising in the
BER route after misinsertion of a nucleotide by reparative
DNA polymerases. These properties would make the enzyme
well fitted for the correction of possible misinsertions during a
viral BER pathway. It can also be seen in Fig. 4 that E. coli
endo IV, which was carried as a control in these experiments,
shows, like the viral AP endonuclease, a strong preference for
mismatched substrates (compare lanes 2 and 7 with lanes 12
and 17).
The Km and catalytic efficiency values obtained for the en-
donucleolytic activity of the viral AP endonuclease were 53.4
nM and 1.07 min1 nM1, respectively. These values are com-
parable to those reported for endo IV (17) and human Ape1
(43). On the other hand, the Km and catalytic efficiency values
for the 335 exonuclease activity of the viral enzyme on the
nicked substrate with a mismatch were 180 nM and 0.45 min1
FIG. 2. Expression and purification of recombinant ASFV pE296R
protein. A Coomassie blue-stained gel after 12% SDS-PAGE separa-
tion of total extracts from control noninduced (T) and IPTG-induced
(T) E. coli BL21(DE3)/pLysS cells transformed with the recombi-
nant plasmid pRSET-E296R is shown. The soluble (S) fraction of the
latter extract and the purified fraction (Ni-NTA) obtained after Ni-
NTA affinity chromatography of the soluble fraction are also shown.
The electrophoretic migration of molecular size markers is indicated
on the left. The arrow shows the expected position of the recombinant
protein.
TABLE 1. Sequences of oligonucleotides used in this work
Name Sequence (533)
	E296R-1.............GAGGGACCGGACCTCTATAG
	E296R-2.............TCATTCTCTATTGTAATGCGC
EndoU..................ATATACCGCGGUCGGCCGATCAAGCTTATT
EndoG..................AATAAGCTTGATCGGCCGGCCGCGGTATAT
Endo11 .................ATATACCGCGG
Endo11MM..........ATATACCGCGA
Endo19 .................CCGGCCGATCAAGCTTATT
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nM1, respectively, which are in the range of those found for
the endonucleolytic activity.
Expression and immunolocalization of ASFV AP endonucle-
ase in infected cells. In order to explore the role of the viral AP
endonuclease during infection, we first analyzed the expression
of this enzyme in Vero cells infected with the BA71V strain of
ASFV. As shown in Fig. 5, Western blot analysis of extracts
from infected cells using an antibody prepared against the
purified recombinant pE296R protein revealed the presence of
a specific band migrating at the expected position for the
pE296R protein. This band was first observed at 6 h postin-
fection (hpi) and accumulated for up to 20 hpi. The protein
was expressed in the presence of cytosine arabinoside (AraC),
an inhibitor of viral DNA replication and late transcription,
indicating that it is an early protein, although it was also
present at late times postinfection. On the other hand, as also
shown in this figure, the protein is not a structural component
of the virus particle.
We next determined the localization of the pE296R protein
by immunofluorescence analysis with the anti-pE296R anti-
body. The cells were also stained with an anti-tubulin antibody
to identify the cytoplasm and with an antibody against the viral
late protein p54 as a marker of viral factories (30). Confocal
images of mock-infected and ASFV-infected cells are shown in
Fig. 6. Essentially no background signal was detected in mock-
infected cells with the anti-pE296R antibody. At early times
postinfection (6 and 8 hpi), the viral AP endonuclease was
found in both the nucleus and the cytoplasm, while at later
times (12 and 16 hpi) the protein was found only in the cyto-
plasm, where it appeared dispersed throughout but also local-
ized in the viral factories. Interestingly, in the presence of
AraC, the viral AP endonuclease was retained in the nucleus,
possibly as a consequence of the blockage in virus replication.
The strong signal detected in the nucleus under these condi-
tions suggests that the disappearance of the AP endonuclease
from the nucleus at late times in the absence of AraC is not
due to degradation of the protein, but rather to its exit from
the nucleus at these times. It can also be seen in this figure that
FIG. 3. (A) AP endonuclease activity of ASFV pE296R protein. The 5-32P-labeled 30-mer double-stranded oligonucleotide (EndoU/EndoG)
substrate (1 pmol) containing a U-G pair at position 12 was treated simultaneously with 0.5 units of UDG to create an AP site and the following
amounts of purified pE296R protein: 30, 60, 90, 120, and 200 ng (lanes 5, 6, 7, 8, and 9, respectively). E. coli endo IV (0.5 units) was used as a
control (lane 4). Results for mixtures containing only UDG (0.5 units), endo IV (0.5 units), and pE295R (90 ng) are shown in lanes 1, 2, and 3,
respectively. The reaction was monitored by autoradiography after resolution in a 20% polyacrylamide-7 M urea gel. The position of the 11-mer
product is indicated. (B) Optimal pH (B1), salt (B2), and magnesium (B3) conditions for AP endonuclease activity of pE296R. To study pH
dependence, the following buffers were used: 20 mM sodium acetate for pHs 5.5 and 6, 20 mM PIPES [piperazine-N,N-bis(2-ethanesulfonic acid)]
for pHs 6, 6.5, and 7, and 20 mM Tris-HCl for pHs 7, 7.5, 8, and 8.5. Each point is the mean of three independent experiments.
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no signal was detected with the anti-pE296R antibody in cells
infected with a deletion mutant lacking this protein (see be-
low), indicating that the signal observed was not due to a
cellular protein that might be induced during infection.
We also tested whether leptomycin B, an inhibitor of the
CMR1-dependent pathway of nuclear export (19), blocks the
release of the viral AP endonuclease from the nucleus. We
found that in contrast with the case for AraC, treatment of the
infected cells with 20 ng/ml of leptomycin B did not cause a
significant retention of the viral enzyme in the nucleus, sug-
gesting that the CRM1-dependent route does not play a major
role in the exit of the viral enzyme from the nucleus at late
times postinfection (not shown).
Replication of the deletion mutant vE296R in Vero cells
and swine macrophages. To further examine the function of
the ASFV AP endonuclease in infection, we constructed a
recombinant E296R gene deletion mutant (v	E296R) as de-
scribed in Materials and Methods. The v	E296R deletion mu-
tant was generated by homologous recombination in cultured
Vero cells, which indicates that the viral AP endonuclease is
not an essential protein for virus replication in this cell type.
However, the viral endonuclease, if it is indeed involved in a
reparative BER pathway, might be required for virus replica-
tion in its natural host cell, the swine macrophage, which pro-
duces and releases ROS in response to stimulation by various
agents (10). This oxidative and potentially genotoxic environ-
ment might cause lesions in the viral DNA whose repair via a
BER system could be essential to prevent a deleterious effect
on the virus. We therefore compared the growth of the paren-
tal BA71V virus with that of the deletion mutant v	E296R in
both Vero cells and swine macrophages. As shown in Fig. 7A,
the mutant and parental viruses replicated with the same ki-
netics and essentially to the same extent in Vero cells, con-
firming that deletion of the AP endonuclease gene has no
effect on ASFV replication in this cell type. In contrast, the
total yield of mutant virus in cultured porcine macrophages
was reduced to 2 to 4% that of the parental virus (Fig. 7B).
This finding indicates that the viral AP endonuclease plays an
essential role in virus growth in its natural target cell.
To investigate the stage at which the growth of the ASFV
deletion mutant in macrophages is blocked, we first compared
the extents of virus DNA synthesis in cells infected with the
parental and mutant viruses. For this comparison, the infected
macrophages were labeled with [3H]thymidine for a 12-h pe-
riod, and the acid-insoluble radioactivity was measured at dif-
ferent times postinfection. Figure 7C shows that although
there was a slight delay in the onset of viral DNA replication in
cells infected with the deletion mutant, the amount of viral
DNA synthesized at 10 to 12 hpi was about 70% of that ob-
tained with the parental virus. This difference probably does
not account for the strong decrease in the production of infec-
tious progeny virus.
We then analyzed the expression of late viral proteins in
macrophages infected with the parental and mutant viruses by
determining by Western blotting the levels of the structural
protein pE248R and the nonstructural protein pB119L (28) at
different times postinfection. As shown in Fig. 7D, the expres-
sion of these two proteins was considerably reduced in macro-
FIG. 4. 335 exonuclease activity of ASFV pE296R protein. The 5-32P-labeled double-stranded oligonucleotide substrate (1 pmol) was
treated with the following amounts of purified pE296R protein: 35 ng (lanes 3, 8, 13, and 18), 100 ng (lanes 4, 9, 14, and 19), and 200 ng (lanes
5, 10, 15, and 20). Lanes 2, 7, 12, and 17 show control reactions with 5 units of endo IV. Lanes 1, 6, 11, and 16 show control reactions with no
enzyme. The reaction products were monitored by autoradiography after resolution in a 20% polyacrylamide-7 M urea gel.
FIG. 5. Western blot analysis of cell extracts from ASFV-infected
cells with the anti-pE296R antibody. Immunoblotting was carried out
for mock-infected (mock) and ASFV-infected cells harvested at the
indicated times postinfection. Results obtained with cells infected for
16 h in the presence of 40 g/ml of cytosine arabinoside (AraC) are
also shown. A sample of 2 g of highly purified ASFV (lane ASFV)
was also analyzed. The band corresponding to the pE296R protein is
indicated by an arrow. The levels of -actin are also shown as a loading
control.
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phages infected with the deletion mutant virus compared with
the parental BA71V virus. This defect in late protein expres-
sion observed with the ASFV deletion mutant may significantly
contribute to the reduction in virus yield.
DISCUSSION
Our results show that ASFV protein pE296R, predicted to
be a class II AP endonuclease, possesses endonucleolytic ac-
tivity specific for abasic sites. Biochemical characterization of
the purified recombinant enzyme, with determination of the
kinetic parameters for the endonucleolytic reaction on AP
substrates, has shown that the Km and catalytic efficiency values
for the viral AP endonuclease are in the range of those re-
ported for E. coli endo IV (17) and human Ape1 (43). In
addition to the endonuclease activity, the viral enzyme has, as
do other class II AP endonucleases, a 335 exonuclease ac-
tivity, with Km and catalytic efficiency values comparable to
those found for the endonucleolytic activity. Several features of
the 335 exonuclease activity of the viral enzyme are of spe-
cial interest. The activity is essentially restricted to the last
nucleotide at the 3 end and is considerably more efficient at
eliminating a mismatch than a correctly paired base. These
properties make the enzyme most suitable for performing a
proofreading function during viral DNA repair by a BER
system.
The resolution of the E. coli endo IV three-dimensional
structure (15) demonstrated that it is a single-domain  pro-
tein with secondary structure elements arranged as a -barrel,
with eight parallel -strands surrounded by eight peripheral
-helices (Fig. 8A). The alignment shown in Fig. 1 and the
ASFV pE296R three-dimensional structure prediction made
by homology modeling using endo IV allowed us to deduce
that the viral protein maintains the 88 folding (Fig. 8B). The
main differences are due to an insertion of two amino acids in
the 11 loop and to a gap in the 3 helix and 44 loop of the
pE296R protein (Fig. 1). This loop, as well as the 55 loop, is
not well conserved in the ASFV protein, which leads to the loss
of A and B strands. The 11 loop, as can be seen in Fig.
8B, could interfere to some extent with the binding of the
FIG. 7. (A and B) Growth curves of parental BA71V and mutant v	E296R viruses in Vero cells (A) and swine macrophage cultures (B). Vero
cells or swine macrophages were infected with BA71V or v	E296R at an MOI of 2 PFU per cell. At different times postinfection, samples were
collected and titrated by plaque assay on fresh Vero cells as previously described (8). (C) Viral DNA synthesis in macrophages infected with
parental BA71V or mutant v	E296R virus. Swine macrophages infected with the parental or mutant virus as described for panel B, as well as
mock-infected cultures, were labeled with 5 mCi/ml of [3H]thymidine (80 Ci/mmol) for a 12-h period. At the indicated times postinfection, samples
were collected, and the acid-insoluble radioactivity was measured. (D) Expression of late viral proteins in macrophages infected with parental or
mutant virus. Macrophage cultures were mock infected or infected as described for panel B, and at the indicated times, the expression of the late
viral proteins pE248R and pB119L was examined by Western blotting using specific antibodies against these proteins (28). The positions of the
pE248R and pB119L proteins, as well as -actin as a loading control, are indicated by arrows. Molecular size markers are indicated on the left.
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pE296R protein to DNA, which is shown superimposed in the
figure. However, a similar loop is also found in the three-
dimensional structure of B. anthracis endo IV, which has re-
cently been resolved (accession no. 1XP3 in the RCSB Protein
Data Bank [M. J. Fogg, V. M. Levdikov, E. V. Blagova, J. A.
Brannigan, A. J. Wilkinson, and K. S. Wilson, unpublished
data]). In this regard, it should be mentioned that a model of
the pE296R protein that we built using the endonuclease of B.
anthracis as a template (not shown) also maintains folding
similar to that of the E. coli protein-based model.
Endo IV contains a trinuclear Zn2 cluster at its active site,
and because the phosphodiester bond of the sugar-phosphate
backbone is always cleaved by a three-metal-ion mechanism,
all of the repair activities of endo IV have been explained by
the cleavage activity of this active site (15). In endo IV, the AP
site is stabilized by stacking interactions of the enzyme with
both 5 and 3 base pairs, with residues Tyr72 and Leu73 at the
5 side and Arg37 at the 3 side filling up the AP site and
bracing DNA in a dramatically bent conformation. Again, in
the modeled viral protein, the conserved residues in the cata-
lytic center are located in the same positions as those in endo
IV (compare Fig. 8C and D). Because of this catalytic center
FIG. 8. Three-dimensional structure prediction for ASFV pE296R protein by homology modeling inferred from the structure of E. coli endo
IV. The structure of endo IV bonded to AP site-containing DNA (15) (A and C) was used as a template (accession no. 1QUM in the RCSB Protein
Data Bank), and the structure was predicted for the ASFV pE296R protein (B and D), with DNA strands shown as blue lines,  helices shown
as red coils, and  strands shown as yellow arrows. Zn atoms are indicated by dots (A and B). The AP site-containing DNA from the 1QUM
structure has been superimposed on the pE296R protein model in panels B and D. The ASFV protein pE296R model was obtained with the
SwissModel server (34), using the alignment shown in Fig. 1. Panels C and D show the high similarity between catalytic center residue dispositions
in the 1QUM template (C) and the model obtained for the ASFV pE296R protein (D).
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disposition, the E. coli enzyme does not make specific contacts
with the base opposite the AP site, which is consistent with the
finding in biochemical studies that E. coli endo IV shows no
preference for the base opposite the AP site (16, 17). However,
we have found that the 335 exonuclease activities of both
endo IV of E. coli and ASFV protein pE296R show a strong
preference for mismatched base pairs. This may suggest the
existence in the two enzymes of recognition mechanisms which
discriminate between correctly and incorrectly paired bases. In
summary, the three-dimensional prediction for ASFV protein
pE296R underscores the structural similarities between E. coli
endo IV and the viral enzyme, which support a common mech-
anism for the cleavage reaction.
The ASFV AP endonuclease, together with the viral Pol X
and ligase, could act in a short-patch BER-like system to main-
tain the integrity of the virus genome in the potentially geno-
toxic environment of the macrophage, the main target cell in
natural infections. Macrophages are known to generate ROS
in response to a variety of stimuli (10). These free radicals
could cause lesions in the bases of the viral DNA that, if
uncorrected, would have a deleterious effect on the virus. The
efficiency of a BER system in preventing DNA damage will rely
on the accuracy of the repair reaction. In relation to this, a
previous biochemical characterization of ASFV Pol X in our
laboratory (14) showed that its nucleotide insertion fidelity is
comparable to that of mammalian Pol  (1, 5). The present
finding that the viral AP endonuclease has a 335 exonucle-
ase activity raises the possibility that the enzyme could also
provide a proofreading activity to correct possible errors made
by the viral reparative polymerase during the gap-filling step,
thus increasing the fidelity of the viral BER system.
Since the ASFV reparative polymerase is expressed at late
times postinfection (27), a Pol X-dependent short-patch BER
would act only at these times, possibly to correct misincorpo-
rations during viral DNA replication or to protect already
replicated genomes. The viral AP endonuclease, which is
present in the infected cell at these late times and is in part
localized in the virus factory, could participate in such a late
viral BER process. It should also be taken into account that,
unexpectedly, the viral endonuclease was found to be ex-
pressed at early times of infection. In contrast with the exclu-
sively cytoplasmic localization of the protein at late times
postinfection, the early enzyme is present in both the cyto-
plasm and the nucleus. The function of the nuclear early en-
zyme is intriguing. In relation to this, it should be mentioned
that human Ape1 also functions in reductively activating cer-
tain transcription factors, such as c-Jun and p53 (9, 45). How-
ever, the viral enzyme lacks the Cys65 residue involved in the
redox function of human Ape1 (41). On the other hand, the
possibility that the ASFV AP endonuclease could play, in ad-
dition to a role in DNA repair, an essential function in virus
replication is unlikely, since the enzyme is not required for
virus growth in Vero cells. It is thus possible that the early
endonuclease could perform a repair role related to the nu-
clear phase of viral DNA replication. The finding that the
enzyme disappears from the nucleus at the times when the
nuclear stage of replication is completed (13, 32), together with
the observation that it is retained in this compartment under
conditions that block viral DNA replication, is in line with this
possibility. A repair system that might function to protect the
viral DNA in the nucleus would, however, be Pol X indepen-
dent and might involve the participation of the viral replicative
DNA polymerase, which is expressed at early times postinfec-
tion (31). Further work will be needed to clarify this question.
The existence of a viral reparative system in infected cells is
supported by the results obtained with the ASFV deletion
mutant lacking the AP endonuclease gene. The finding that the
viral endonuclease is needed for virus growth in swine macro-
phages but not in Vero cells suggests that this requirement is
related to the induction of more extensive damage in the viral
DNA due to the highly oxidative environment of the macro-
phage. In the absence of the viral AP endonuclease, the oxi-
dative lesions caused in the virus DNA might not be repaired,
which would lead to a decrease in the production of infectious
progeny virus. The block in the growth of the deletion mutant
may be due, at least in part, to a defect in late protein expres-
sion, possibly originating by alterations in viral gene transcrip-
tion as a consequence of accumulated DNA lesions. However,
the packaging of mutated genomes in progeny viruses might
also contribute to the reduction in virus yield. In relation to
these observations, it is interesting that endo IV has been
reported as a DNA damage-inducible essential factor for oxi-
dative injury resistance in E. coli (21, 26).
Our observations with the ASFV deletion mutant lacking
the AP endonuclease are not in agreement with the proposal
made by others that the ASFV BER system is a mutagenic
system that would account for virus variability (35, 36). Instead,
our findings support the existence of an ASFV reparative BER
system to maintain the viability of the virus in the infected
macrophage.
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